Conservative initial postoperative anticoagulation strategy after HeartMate 3 left ventricular assist device implantation.

Kevin DammanStan A J van den BroekGianclaudio MecozziJoep M DrooghEthel MetzAnnemieke Oude LansinkJan A KrikkenMichiel E ErasmusMichiel Kuijpers

Published in: Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation (2022)

These retrospective data suggest that conservative slow initiation of anticoagulation therapy after HM3 LVAD implantation is associated with less bleeding/tamponade events requiring reoperation, a similar safety profile and a shorter duration of stay than the currently advised standard anticoagulation protocol.

Keyphrases

left ventricular assist device
atrial fibrillation
venous thromboembolism
randomized controlled trial
patients undergoing
cross sectional
electronic health record
big data
stem cells
machine learning
cell therapy